| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,396 |
4,104 |
$208K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,694 |
2,559 |
$205K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,568 |
1,564 |
$158K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,317 |
1,313 |
$123K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,109 |
1,101 |
$103K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
779 |
770 |
$75K |
| 99215 |
Prolong outpt/office vis |
505 |
489 |
$59K |
| 99188 |
|
718 |
717 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
292 |
280 |
$4K |
| 99381 |
|
37 |
37 |
$4K |
| 92552 |
|
590 |
583 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
52 |
51 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
149 |
80 |
$2K |
| 99173 |
|
936 |
928 |
$2K |
| 99177 |
|
843 |
842 |
$1K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
33 |
33 |
$1K |
| 90686 |
|
828 |
776 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,822 |
1,815 |
$1K |
| 92551 |
|
1,472 |
1,469 |
$886.28 |
| 96127 |
|
1,075 |
1,066 |
$857.24 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
34 |
34 |
$765.20 |
| 80061 |
Lipid panel |
409 |
409 |
$725.88 |
| 96160 |
|
1,074 |
1,065 |
$670.77 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
16 |
15 |
$624.64 |
| 90670 |
|
380 |
355 |
$484.00 |
| 96161 |
|
976 |
969 |
$386.83 |
| 87807 |
|
25 |
25 |
$339.61 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
26 |
26 |
$329.16 |
| 81002 |
|
86 |
84 |
$316.36 |
| 99174 |
|
87 |
87 |
$222.72 |
| 85018 |
|
409 |
408 |
$169.64 |
| 83655 |
|
468 |
467 |
$145.35 |
| G9920 |
Screening performed and negative |
1,455 |
1,450 |
$0.00 |
| 90633 |
|
331 |
331 |
$0.00 |
| 90648 |
|
636 |
636 |
$0.00 |
| 90715 |
|
77 |
77 |
$0.00 |
| 90710 |
|
70 |
70 |
$0.00 |
| 90681 |
|
14 |
14 |
$0.00 |
| 90707 |
|
26 |
26 |
$0.00 |
| 90700 |
|
14 |
14 |
$0.00 |
| 90661 |
|
121 |
121 |
$0.00 |
| 90723 |
|
585 |
585 |
$0.00 |
| 90696 |
|
56 |
56 |
$0.00 |
| 90651 |
|
210 |
210 |
$0.00 |
| 90680 |
|
422 |
422 |
$0.00 |
| 90677 |
|
431 |
431 |
$0.00 |
| 90647 |
|
34 |
34 |
$0.00 |
| 90620 |
|
111 |
111 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
624 |
616 |
$0.00 |
| 90619 |
|
214 |
214 |
$0.00 |
| 90716 |
|
26 |
26 |
$0.00 |
| 90656 |
|
100 |
100 |
$0.00 |